Despite the fact that the apoB/apoA1 ratio has also been proposed as a meaningful marker, prior evidence suggests that apoB alone is a superior predictor of CAD mortality, with the predictive power of the ratio largely driven by apoB itself. The gene discussed is APOB; the disease is coronary artery disorder.